Provider Markets

Evaluating Trends in Healthcare Provider Markets

Healthcare providers are under increasing pressure while industry consolidation, insurance complexity and other factors are further complicating the market and impacting access to care. Schaeffer scholars evaluate these trends and offer solutions.

Top Stories View All

Perspective

Federally Fueled Hospital Drug Sales Must Be Reformed

The 340B drug discount program has grown rapidly while straying from its mission of serving uninsured patients and safety-net providers, Schaeffer Scholars Ryan Long and Karen Mulligan write in a new Washington Examiner op-ed. A recent Schaeffer Center white paper shows the 340B program’s “buy low, sell high” incentive is at the heart of the…

Featured Experts: Ryan Long, Karen Mulligan

Journal Article

Inpatient Prices in Medicare Advantage Vary Modestly Across and Within Hospitals

News

Reform of Federal Drug Discount Program Should Target Misaligned Incentives

Perspective

When Patient Access to Results Complicates Care

In The News View All

Los Angeles Times

Melnick interviewed about rural hospitals’ financial struggles

Featured Experts: Glenn Melnick

KFF Health News

Melnick discusses the forces driving healthcare consolidation

Featured Experts: Glenn Melnick

Spectrum News

Frasco quoted on the likelihood Congress will extend Medicare telehealth coverage

Featured Experts: Melissa A. Frasco

Medscape

Ginsburg explains the need to reform Medicare’s process for setting physician payments

Featured Experts: Paul Ginsburg

HealthLeaders Media

Long discusses why 340B reform is needed to better serve low-income patients

Featured Research

Dialysis Costs the Healthcare System Three Times More in the Individual Market

Monthly spending on outpatient dialysis services for patients with end-stage kidney disease was three times higher for patients insured in the individual market compared to patients insured through Medicare.

Experts: Erin Trish, Eugene Lin